Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Linaclotide Capsules

Approval Number

国药准字HJ20190001

CompanyAstraZeneca AG

Registration Date

October 16, 2023

Previous Approval Numbers

H20190001

Drug Information

Generic Name

利那洛肽胶囊

Trade Name

令泽舒

Dosage Form

胶囊剂

Strength

290μg

Drug Type

化学药品

Registration Date

October 16, 2023

Expiry Date

October 15, 2028

Company Information

Applicant Company

Company NameAstraZeneca AG

Company Address

Neuhofstrasse 34, 6340 Baar, Switzerland

Manufacturing Company

Company NameALMAC PHARMA SERVICES LIMITED

Company Address

Seagoe Industrial Estate, Portadown, Craigavon, County Armagh, BT63 5UA, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy